Table I.
Clinical characteristics of patients 1 and 2 with pili torti and chronic graft-vs-host disease
| HSCT indication | Induction regimen | Donor characteristics | Age at presentation, y | HSCT date | Time from HSCT to clinical presentation, month |
|---|---|---|---|---|---|
| AML | Cytarabine, daunorubicin | Matched related donor (brother, sex discordant) | 47 | August 27, 2015 | 20 |
| AML | RIC busulfan, fludarabine | Matched related donor (sister, sex concordant) | 66 | January 12, 2015 | 56 |
AML, Acute myeloid leukemia; HSCT, hematopoietic stem cell transplant; RIC, reduced intensity conditioning.